Beckman Coulter will use the platform to unify data across its instruments and systems to provide standardized performance metrics and AI-based analytics.

Last week, readers were most interested in a story about Dxcover's platform, which integrates infrared spectroscopy with proprietary algorithms, receiving Class C certification.

The firm expects to reach patients who might otherwise avoid medical appointments by offering screening tests through dentists.

The system consists of a microfluidic cartridge with 640 incubation wells that allows the platform to visually test all clinically relevant antibiotics quantitatively.

The Phase II study will evaluate CytoDyn's leronlimab in combination with TAS-102 and bevacizumab in patients with relapsed or refractory metastatic colorectal cancer.

The Irvine, California-based company will now market its test to clinical labs throughout the UK for patient testing.

The award supports development of a portable test system using the firm's protein nucleic acid probes and semiconductor sensor tech.

The software is designed to analyze digital pathology whole-slide images of skin lesions and aid pathologists in their review.

The platform analyzes infrared spectroscopy data from a small sample of blood with proprietary algorithms to detect cancer early.

The firm's Fusion AP digital slide viewing system and AI-based analysis support is now authorized for commercialization in Europe.